Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Number of holders
-
2049
-
Total 13F shares, excl. options
-
1,017,877,459
-
Shares change
-
+24,135,876
-
Total reported value, excl. options
-
$84,919,694,336
-
Value change
-
+$2,053,435,851
-
Put/Call ratio
-
1.03%
-
Number of buys
-
1,019
-
Number of sells
-
-864
-
Price
-
$83.44
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q2 2021
2,229 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q2 2021.
CVS HEALTH Corp - Common Stock (CVS) has 2,049 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,017,877,459 shares
of 1,268,585,398 outstanding shares and own 80.24% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (107,495,739 shares), BlackRock Inc. (96,490,010 shares), STATE STREET CORP (54,535,214 shares), Capital World Investors (46,105,742 shares), Capital International Investors (27,400,512 shares), MORGAN STANLEY (22,137,358 shares), FMR LLC (21,775,610 shares), GEODE CAPITAL MANAGEMENT, LLC (21,149,369 shares), JPMORGAN CHASE & CO (18,017,348 shares), and BANK OF AMERICA CORP /DE/ (17,254,280 shares).
This table shows the top 2049 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.